“With conversion rights,” the vice chairman added quietly.

Ethan nodded. “Triggered by missed milestones, a debt-ratio breach, and two undisclosed lawsuits.”

My mother went pale. “Richard?”

My father ignored her and pointed at me. “This is revenge. You set out to destroy your own family.”

I stood. My legs trembled for a second, then steadied.

“No,” I said. “If I wanted to destroy Bellamy, I would have let you keep running it.”

Caroline’s voice sharpened. “You told me the cash issue was temporary. You said the delayed trial was routine. Did you use my promotion to distract the board?”

He didn’t answer.

Her expression shifted—not to innocence, but to realization. “You did,” she whispered.

Ethan opened the folder he had brought. “Tomorrow at nine, the board will vote on leadership transition, debt restructuring, and emergency compliance measures. Richard Bellamy will be asked to resign as CEO. Caroline Bellamy’s promotion will be suspended pending review.”

My father laughed, but it sounded fractured. “And what? You take my chair?”

Ethan looked at me.

I placed my hand on the folder. “No,” I said. “I do.”

“You can’t,” my father said.

“I can,” I replied. “Because I understand the science, I understand the regulators, and unlike you, I understand what happens when ego runs a laboratory.”

The dinner ended in silence.

The next morning, the Bellamy boardroom smelled of coffee and panic. By nine-twelve, outside counsel confirmed the breach. By nine-twenty, the audit committee recommended immediate leadership changes. By nine-thirty-one, my father was removed as CEO by unanimous vote—except his own.

Then Caroline spoke.

Her voice shook, but she didn’t hide. She admitted she had ignored warning signs because she trusted our father—and because being chosen had felt too good to question. Then she stepped down from the promotion herself.

At nine-forty-six, the board voted to appoint me interim CEO for twelve months, with full restructuring authority. Ethan remained outside governance to avoid conflicts. Bellamy Biotech did not collapse. It was saved.

Three months later, we had shut down the wasteful division, settled the lawsuits, rebuilt compliance, and kept the therapy program alive by partnering with a university lab in Boston. We also introduced the first promotion policy in company history that banned family appointments.

My father sent one email after that. It contained no apology—only anger.

Caroline sent another.

I was in my office when it arrived. A single line sat in the center of the screen:

You were the daughter all along. I was just the obedient one.

I read it twice.

Then I closed the message and looked through the glass wall of my office—at scientists moving between labs, at people working without fear, at a company nearly buried by my father’s pride.

I never replied.

Because I hadn’t bought Bellamy to be loved.

I bought it so no one at that table would ever define my worth again.